Form D · Biotechnology
TISSUE GENESIS INC.
Honolulu, HI · CIK 0001210070
Offering snapshot reported Sep 3, 2014 · SEC filing
- Reported sold
- $500K Offering amount: $6M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 22, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 3, 2014 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jan 4, 2012 | Initial | $7,737,709 | No comparison | 53 | SEC filing |
| Jul 11, 2011 | Initial | $5,634,005 | No comparison | 51 | SEC filing |
| Jan 5, 2011 | Initial | $4,461,600 | No comparison | 40 | SEC filing |
| Jul 2, 2010 | Initial | $1,330,400 | No comparison | 9 | SEC filing |
| Apr 22, 2010 | Initial | $120,000 | No comparison | 2 | SEC filing |
| Apr 22, 2010 | Initial | $1,120,000 | No comparison | 3 | SEC filing |
| Jan 26, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 15, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 24, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-223973
Source: Form D, filed Sep 3, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Cannon | Director, Executive |
| Robert Hiam | Director |
| Paul Kosnik | Executive |
| Anton C. Krucky | Director, Executive |
| Bradley Perkins | Executive |
| Hiam Robert | Director |
| Lawrence Rodriguez | Director |
| Michael Ruley | Director |
| Timothy Sarhatt | Director |
| Jeffery Watanabe | Director |
| Jeffrey Watanabe | Director |
| Jeff Watanabe | Director |
| William Wiesmann | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
810 Richards Street Suite 1000
Honolulu, HI, 96813
Honolulu, HI, 96813